Regulatory T cells and cancer
- PMID: 17306521
- DOI: 10.1016/j.coi.2007.02.004
Regulatory T cells and cancer
Abstract
Increasing evidence indicates that T regulatory (Treg) cells have the potent ability to suppress host immune responses, thus preventing autoimmune diseases. However, recent studies demonstrate that tumor cells can recruit these Treg cells to inhibit antitumor immunity in the tumor microenvironment, thus limiting the efficiency of cancer immunotherapy. Tumor-specific Treg cells have recently been identified and characterized, providing compelling evidence that such antigen-specific Treg cells can induce tumor-specific local immune tolerance. Vaccine strategies designed to overcome tumor-associated immune suppression are crucial to successful immunotherapy. Recent findings indicate that Toll-like receptors directly regulate the suppressive activity of human Treg cells, which might offer new opportunities to improve the outcome of cancer immunotherapy by co-administration of certain Toll-like receptor ligands and antigenic peptides.
Similar articles
-
Regulatory T cells and Toll-like receptors in tumor immunity.Semin Immunol. 2006 Apr;18(2):136-42. doi: 10.1016/j.smim.2006.01.008. Epub 2006 Feb 15. Semin Immunol. 2006. PMID: 16469504 Review.
-
Regulatory T cells and toll-like receptors in cancer therapy.Cancer Res. 2006 May 15;66(10):4987-90. doi: 10.1158/0008-5472.CAN-05-4676. Cancer Res. 2006. PMID: 16707417 Review.
-
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817828 Review.
-
Functional control of regulatory T cells and cancer immunotherapy.Semin Cancer Biol. 2006 Apr;16(2):106-14. doi: 10.1016/j.semcancer.2005.11.004. Epub 2006 Jan 19. Semin Cancer Biol. 2006. PMID: 16423537 Review.
-
Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.Semin Cancer Biol. 2006 Feb;16(1):73-9. doi: 10.1016/j.semcancer.2005.07.009. Epub 2005 Sep 6. Semin Cancer Biol. 2006. PMID: 16140545 Review.
Cited by
-
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases.Mediterr J Hematol Infect Dis. 2012;4(1):e2012053. doi: 10.4084/MJHID.2012.053. Epub 2012 Aug 9. Mediterr J Hematol Infect Dis. 2012. PMID: 22973497 Free PMC article.
-
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.Oncoimmunology. 2015 Apr 2;4(3):e990800. doi: 10.4161/2162402X.2014.990800. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949908 Free PMC article.
-
Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.Cancer Immunol Immunother. 2013 Jun;62(6):1123-30. doi: 10.1007/s00262-013-1424-8. Epub 2013 Apr 21. Cancer Immunol Immunother. 2013. PMID: 23604172 Free PMC article.
-
The role of regulatory T cells in cancer.Immune Netw. 2009 Dec;9(6):209-35. doi: 10.4110/in.2009.9.6.209. Epub 2009 Dec 31. Immune Netw. 2009. PMID: 20157609 Free PMC article.
-
Update on toll-like receptor-directed therapies for human disease.Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii77-80. doi: 10.1136/ard.2007.078998. Ann Rheum Dis. 2007. PMID: 17934102 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources